Part E — Price Negotiation Program To Lower Prices for Certain High-Priced Single Source Drugs
- §1320f Establishment of program
- §1320f–1 Selection of negotiation-eligible drugs as selected drugs
- §1320f–2 Manufacturer agreements
- §1320f–3 Negotiation and renegotiation process
- §1320f–4 Publication of maximum fair prices
- §1320f–5 Administrative duties and compliance monitoring
- §1320f–6 Civil monetary penalties
- §1320f–7 Limitation on administrative and judicial review